302 related articles for article (PubMed ID: 33352888)
1. The VP1u of Human Parvovirus B19: A Multifunctional Capsid Protein with Biotechnological Applications.
Ros C; Bieri J; Leisi R
Viruses; 2020 Dec; 12(12):. PubMed ID: 33352888
[TBL] [Abstract][Full Text] [Related]
2. A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells.
Bircher C; Bieri J; Assaraf R; Leisi R; Ros C
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216013
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.
Leisi R; Ruprecht N; Kempf C; Ros C
J Virol; 2013 Dec; 87(24):13161-7. PubMed ID: 24067971
[TBL] [Abstract][Full Text] [Related]
4. The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.
Leisi R; Di Tommaso C; Kempf C; Ros C
Viruses; 2016 Feb; 8(3):61. PubMed ID: 26927158
[TBL] [Abstract][Full Text] [Related]
5. The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.
Leisi R; Von Nordheim M; Ros C; Kempf C
Viruses; 2016 Sep; 8(10):. PubMed ID: 27690083
[TBL] [Abstract][Full Text] [Related]
6. Specific Targeting of Proerythroblasts and Erythroleukemic Cells by the VP1u Region of Parvovirus B19.
Leisi R; von Nordheim M; Kempf C; Ros C
Bioconjug Chem; 2015 Sep; 26(9):1923-30. PubMed ID: 26240997
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal 5-68 amino acids domain of the minor capsid protein VP1 of human parvovirus B19 enters human erythroid progenitors and inhibits B19 infection.
Zou W; Ning K; Xu P; Deng X; Cheng F; Kleiboeker S; Qiu J
J Virol; 2021 Jun; 95(14):. PubMed ID: 33952637
[TBL] [Abstract][Full Text] [Related]
8. Structural Dynamics and Activity of B19V VP1u during the pHs of Cell Entry and Endosomal Trafficking.
Lakshmanan RV; Hull JA; Berry L; Burg M; Bothner B; McKenna R; Agbandje-McKenna M
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146728
[TBL] [Abstract][Full Text] [Related]
9. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.
Bieri J; Ros C
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341051
[TBL] [Abstract][Full Text] [Related]
10. Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19.
Nogueira MLC; Lakshmanan R; Rivière G; Mietzsch M; Bennett A; McKenna R; Long JR
Biomol NMR Assign; 2024 Jun; ():. PubMed ID: 38904726
[TBL] [Abstract][Full Text] [Related]
11. Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19.
Caldas Nogueira ML; Lakshmanan R; Rivière G; Mietzsch M; Bennett A; McKenna R; Long JR
Res Sq; 2024 Jun; ():. PubMed ID: 38883784
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of Domain Segmentation of B19V VP1u Using Intein Technology for Structural Studies.
Lakshmanan RV; Agbandje-McKenna M; McKenna R
Protein Pept Lett; 2024; 31(2):161-167. PubMed ID: 38243925
[TBL] [Abstract][Full Text] [Related]
13. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.
Bönsch C; Kempf C; Ros C
J Virol; 2008 Dec; 82(23):11784-91. PubMed ID: 18815302
[TBL] [Abstract][Full Text] [Related]
14. The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.
Deng X; Dong Y; Yi Q; Huang Y; Zhao D; Yang Y; Tijssen P; Qiu J; Liu K; Li Y
PLoS One; 2013; 8(4):e61440. PubMed ID: 23596524
[TBL] [Abstract][Full Text] [Related]
15. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.
Hsu TC; Chiu CC; Chang SC; Chan HC; Shi YF; Chen TY; Tzang BS
Virulence; 2016; 7(2):110-8. PubMed ID: 26632342
[TBL] [Abstract][Full Text] [Related]
16. The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization.
Bönsch C; Zuercher C; Lieby P; Kempf C; Ros C
J Virol; 2010 Nov; 84(22):11737-46. PubMed ID: 20826697
[TBL] [Abstract][Full Text] [Related]
17. Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome.
Lin CY; Chiu CC; Cheng J; Lin CY; Shi YF; Tsai CC; Tzang BS; Hsu TC
Virulence; 2018 Jan; 9(1):208-216. PubMed ID: 28960143
[TBL] [Abstract][Full Text] [Related]
18. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
[TBL] [Abstract][Full Text] [Related]
19. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.
Ros C; Gerber M; Kempf C
J Virol; 2006 Dec; 80(24):12017-24. PubMed ID: 17020940
[TBL] [Abstract][Full Text] [Related]
20. Human parvovirus B19 interacts with globoside under acidic conditions as an essential step in endocytic trafficking.
Bieri J; Leisi R; Bircher C; Ros C
PLoS Pathog; 2021 Apr; 17(4):e1009434. PubMed ID: 33878123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]